| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060003999 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | CA2571309A1 Chemical compounds |
| 01/05/2006 | CA2571258A1 Amido compounds and their use as pharmaceuticals |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain |
| 01/04/2006 | EP1611116A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1408030B1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
| 01/04/2006 | CN1715276A Process for preparing high purity roxatidine acetate and its salts |
| 01/04/2006 | CN1715275A Simple process for preparing trimetazidine and its medicinal salts |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234697C Method of producing N-substituted 2, 6-dialdyl morpholines |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2359476C Hypolipidemic and antioxidant morpholine derivatives |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123707A1 Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | CA2570064A1 Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | CA2569459A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/28/2005 | EP1608635A1 Phenyl sulfone derivatives and their use in the treatment of cns disorders |
| 12/28/2005 | EP1608617A1 Muscarinic agonists |
| 12/28/2005 | EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors |
| 12/28/2005 | EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/28/2005 | EP1332138B1 Radiopharmaceuticals for diagnosing alzheimer's disease |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | EP1245561B1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/28/2005 | EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/28/2005 | CN1712398A Diaryl amidine compound, its production, medicinal composition and use |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/27/2005 | CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 12/22/2005 | WO2005121088A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 12/22/2005 | WO2005121087A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
| 12/22/2005 | WO2005120477A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 12/22/2005 | WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 12/22/2005 | WO2005063697A3 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 12/22/2005 | WO2004110389A3 Sigma ligands for neuronal regeneration and functional recovery |
| 12/22/2005 | US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/22/2005 | US20050282822 Therapeutic agents |
| 12/22/2005 | US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 12/22/2005 | US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity |
| 12/22/2005 | CA2569843A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 12/21/2005 | EP1606623A2 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/21/2005 | EP1606288A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
| 12/21/2005 | EP1606251A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 12/21/2005 | EP1605752A1 Compounds, compositions and methods |
| 12/21/2005 | EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 12/21/2005 | CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 12/21/2005 | CN1711251A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 12/21/2005 | CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/21/2005 | CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs |
| 12/21/2005 | CN1232519C Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 12/21/2005 | CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 12/21/2005 | CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same |
| 12/20/2005 | US6977301 Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide |
| 12/20/2005 | US6977265 Piperidine CCR-3 receptor antagonists |
| 12/20/2005 | US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases |
| 12/20/2005 | CA2302412C Aminoalkylphenol derivatives and related compounds |
| 12/20/2005 | CA2233560C Sulfonamide inhibitors of matrix metalloproteinases |
| 12/15/2005 | WO2005118543A1 Kinase inhibitor and use thereof |
| 12/15/2005 | WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 12/15/2005 | WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 12/15/2005 | WO2005117543A2 N-sulfonylcarboximidamide apoptosis promoters |
| 12/15/2005 | US20050277681 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 12/15/2005 | US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes |
| 12/15/2005 | US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 12/15/2005 | US20050277627 Colchinol derivatives as vascular damaging agents |
| 12/15/2005 | DE102004022765A1 Verfahren zur Herstellung von Monoarylpiperazinen A process for preparing Monoarylpiperazinen |
| 12/15/2005 | CA2567831A1 N-sulfonylcarboximidamide apoptosis promoters |